Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.2.u1
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
REVENUES        
Revenues $ 26,937 $ 56,053 $ 53,440 $ 214,003
Cost of revenues 16,231 23,570 40,277 55,927
Gross margin 10,706 32,483 13,163 158,076
EXPENSES        
Research and development 67,203 717,667 106,615 784,807
Selling, general and administrative 1,443,171 1,625,471 2,907,652 3,010,813
Total operating expenses 1,510,374 2,343,138 3,014,267 3,795,620
Operating loss (1,499,668) (2,310,655) (3,001,104) (3,637,544)
Other income/(expense), net (74) (321)
Loss before provision (1,499,742) (2,310,655) (3,001,425) (3,637,544)
Provision for income taxes
Net loss (1,499,742) (2,310,655) (3,001,425) (3,637,544)
Other total comprehensive income (loss):        
Change in foreign currency translation, net of tax 121,174 18,849 160,865 28,197
Total other comprehensive income (loss) 121,174 18,849 160,865 28,197
Total comprehensive loss (1,378,568) (2,291,806) (2,840,560) (3,609,347)
Less: comprehensive income attributable to non-controlling interest 156,197 268,894 329,489 401,588
Comprehensive loss attributable to shareholders $ (1,222,371) $ (2,022,912) $ (2,511,071) $ (3,207,759)
Basic earnings per share to shareholders (in Dollars per share) $ (0.54) $ (3.05) $ (1.07) $ (5.46)
Weighted average shares - basic (in Shares) 2,506,015 669,636 2,506,015 592,896